A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing

PURPOSE: As genome-scale sequencing is increasingly applied in clinical scenarios, a wide variety of genomic findings will be discovered as secondary or incidental findings, and there is debate about how they should be handled. The clinical actionability of such findings varies, necessitating standa...

詳細記述

保存先:
書誌詳細
出版年:Genet Med
主要な著者: Berg, Jonathan S., Foreman, Ann Katherine M., O'Daniel, Julianne M., Booker, Jessica K., Boshe, Lacey, Carey, Timothy, Crooks, Kristy R., Jensen, Brian C., Juengst, Eric T., Lee, Kristy, Nelson, Daniel K., Powell, Bradford C., Powell, Cynthia M., Roche, Myra I., Skrzynia, Cecile, Strande, Natasha T., Weck, Karen E., Wilhelmsen, Kirk C., Evans, James P.
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2016
主題:
Original Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4752935/
https://ncbi.nlm.nih.gov/pubmed/26270767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2015.104
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料